Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Z Li

Showing results (21-30 of 270) with videos related to

Pageof 27
Sort By:
The Journal of Infectious Diseases|February 15, 2021
Challenges and Promise of Human Immunodeficiency Virus RemissionYijia Li, Abbas Mohammadi, Jonathan Z Li
The Journal of Infectious Diseases|September 14, 2020
Empowering Inclusion and Diversity in the Field of Infectious DiseasesJonathan Z Li, Cynthia L Sears, Archana Chatterjee
Current Opinion in HIV and AIDS|December 5, 2024
Viral and immune predictors of HIV posttreatment controlFlavio S Mesquita, Yijia Li, Jonathan Z Li
Current Opinion in HIV and AIDS|June 8, 2018
Lessons learned from HIV antiretroviral treatment interruption trialsYing Wen, Katharine J Bar, Jonathan Z Li
The Journal of Infectious Diseases|December 28, 2022
Turning the page: a welcome from the new leadership of the Journal of Infectious DiseasesCynthia L Sears, Jonathan Z Li, Upinder Singh
AIDS (London, England)|April 15, 2015
The need for treatment interruption studies and biomarker identification in the search for an HIV cureJonathan Z Li, Davey M Smith, John W Mellors
The New England Journal of Medicine|April 24, 2024
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19Carlee B Moser, Jonathan Z Li, Michael D Hughes
Antimicrobial Agents and Chemotherapy|September 25, 2003
Virucidal efficacy of soap and water against human immunodeficiency virus in genital secretionsJonathan Z Li, Elizabeth C Mack, Jay A Levy
Plos Computational Biology|July 25, 2019
Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkersJessica M Conway, Alan S Perelson, Jonathan Z Li
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 2026
Is Two Drug Therapy with Dolutegravir and Lamivudine an Appropriate Option for People with HIV and Historic Lamivudine Resistance?Aliza S Green, Jonathan Z Li, Paul E Sax
Pageof 27

Showing results (21-30 of 270) with videos related to

Sort By:
Pageof 27
The Journal of Infectious Diseases|February 15, 2021
Challenges and Promise of Human Immunodeficiency Virus RemissionYijia Li, Abbas Mohammadi, Jonathan Z Li
The Journal of Infectious Diseases|September 14, 2020
Empowering Inclusion and Diversity in the Field of Infectious DiseasesJonathan Z Li, Cynthia L Sears, Archana Chatterjee
Current Opinion in HIV and AIDS|December 5, 2024
Viral and immune predictors of HIV posttreatment controlFlavio S Mesquita, Yijia Li, Jonathan Z Li
Current Opinion in HIV and AIDS|June 8, 2018
Lessons learned from HIV antiretroviral treatment interruption trialsYing Wen, Katharine J Bar, Jonathan Z Li
The Journal of Infectious Diseases|December 28, 2022
Turning the page: a welcome from the new leadership of the Journal of Infectious DiseasesCynthia L Sears, Jonathan Z Li, Upinder Singh
AIDS (London, England)|April 15, 2015
The need for treatment interruption studies and biomarker identification in the search for an HIV cureJonathan Z Li, Davey M Smith, John W Mellors
The New England Journal of Medicine|April 24, 2024
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19Carlee B Moser, Jonathan Z Li, Michael D Hughes
Antimicrobial Agents and Chemotherapy|September 25, 2003
Virucidal efficacy of soap and water against human immunodeficiency virus in genital secretionsJonathan Z Li, Elizabeth C Mack, Jay A Levy
Plos Computational Biology|July 25, 2019
Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkersJessica M Conway, Alan S Perelson, Jonathan Z Li
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 2026
Is Two Drug Therapy with Dolutegravir and Lamivudine an Appropriate Option for People with HIV and Historic Lamivudine Resistance?Aliza S Green, Jonathan Z Li, Paul E Sax
Pageof 27